期刊文献+

雷帕霉素对KB/VCR细胞耐药的逆转作用

Reversal of P-glycoprotein-mediated Multidrug Resistance by Rapamycin in KB/VCR Cells
原文传递
导出
摘要 目的探讨雷帕霉素对人口腔上皮癌耐药细胞株KB/VCR的多药耐药逆转作用及其逆转机制。方法采用四甲基偶氮唑盐(MTT)方法检测KB/VCR细胞中雷帕霉素对VCR的逆转倍数,流式细胞仪检测Rh123在KB和KB/VCR细胞内的蓄积,Western-blot检测雷帕霉素对P糖蛋白(P-gp)表达的影响。结果雷帕霉素显著逆转KB/VCR的耐药性。雷帕霉素能够明显增强Rh123在细胞内的蓄积,同时能够降低P-gp的表达。结论雷帕霉素能够逆转KB/VCR细胞对VCR的耐药性,可能与其抑制P-gp功能和蛋白质表达相关。 Objective To explore the reversal effect and potential mechanism of rapamycin on multidrug resistance of KB/VCR cells. Methods MTT assay was used to investigate reversal index of rapamycin to vincristine. P-gp activity was evaluated by measuring Rh123 accumulation by flow cytometry. Western blot was used to detect the protein expression of P-gp. Results Rapamycin obviously reversed the multidrug resistant phenotype of KB/VCR cells. Further study showed that rapamycin significantly increased the accumulation of Rh123 in KB/VCR cells. Moreover,rapamycin down-regulated the expression of P-gp. Conclusion Rapamycin significantly reverse P-gp-mediated MDR in KB/VCR cells. The potential mechanism may be via inhibiting the activity and expression of P-gp.
出处 《潍坊医学院学报》 2017年第5期321-323,共3页 Acta Academiae Medicinae Weifang
关键词 雷帕霉素 多药耐药 KB/VCR P-糖蛋白 Rapamyein Muhidrug resistance KB/VCR P-glycoprotei
  • 相关文献

参考文献2

二级参考文献21

  • 1Zoncu R, Efeyan A, Sabatini DM. roTOR: from growth signal integration to cancer, diabetes and ageing[J]. Nat Rev Mol Cell Biol, 2011,12 ( 1 ): 21-35.
  • 2Grunwald V, DeGraffenried L, Russel D, et al. Inhibitors of mTOR reverse doxorubicin resistance conferred hy PTEN status in prostate cancer cells[J]. Cancer Res, 2002,62 ( 21 ) : 6141-6145.
  • 3Pop IV, Pop LM, Ghetie MA, et al. Targeting mammalian target of rapamycin to both downregulate and disable the P-glyeoprotein pump in multidrug- resistant B-cell lymphoma cell lines[J]. Leuk Lymphoma,2009,50 (7): 1155-1162.
  • 4Krathen M. Malignant melanoma: Advances in diagnosis, prognosis, and treatment [J]. Semin Cutan Med Surg, 2012, 31(1): 45-49.
  • 5Mi YJ, Liang YJ, Huang HB, et al. Apatinib (YN968D1) re- verses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters [J]. Cancer Res, 2010, 70(20): 7981-7991.
  • 6Jiang BH, Liu LZ. Role of mtor in anticancer drug resistance: perspectives for improved drug treatment [J]. Drug Resist Updat, 2008, 11(3): 63-76.
  • 7La Porta CA. Mechanism of drug sensitivity and resistance in melanoma [J]. Curr Cancer Drug Targets, 2009, 9(3): 391-397.
  • 8Grossman D, Altieri DC. Drug resistance in melanoma: mecha- nisms, apoptosis, and new potential therapeutic targets[J]. Cancer Metastasis Rev, 2001, 20(1-2): 3-11.
  • 9Coutte L, Dreyer C, Sablin MP, et al. P13K-AKT-mTOR path- way and cancer[J]. Bull Cancer, 2012, 99(2): 173-180.
  • 10Gentzler RD, Ahman JK, Platanias LC. An overview of the mTOR pathway as a target in cancer therapy [J]. Expert Opin Ther Targets, 2012, 16(5): 481-489.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部